Patents Assigned to AEGEA BIOTECHNOLOGIES, INC.
  • Patent number: 10590453
    Abstract: The present invention provides methods of amplifying a target nucleic acid utilizing a circularized template. Circularization may be achieved utilizing a bridging oligonucleotide or an inverter primer. The bridging oligonucleotide or inverted primer is extended forming a concatemeric amplicon that can then be used as a template to provide exponential amplification of the target nucleic acid.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: March 17, 2020
    Assignee: AEGEA BIOTECHNOLOGIES, INC.
    Inventors: Lyle J. Arnold, Norman C. Nelson
  • Publication number: 20200002740
    Abstract: The present invention provides methods of amplifying a target nucleic acid utilizing a circularized template. Circularization may be achieved utilizing a bridging oligonucleotide or an inverter primer. The bridging oligonucleotide or inverted primer is extended forming a concatemeric amplicon that can then be used as a template to provide exponential amplification of the target nucleic acid.
    Type: Application
    Filed: August 16, 2018
    Publication date: January 2, 2020
    Applicant: Aegea Biotechnologies, Inc.
    Inventors: Lyle J. Arnold, Norman C. Nelson
  • Publication number: 20190112625
    Abstract: The present invention provides methods of amplifying a target nucleic acid utilizing a circularized template. Circularization may be achieved utilizing a bridging oligonucleotide or an inverter primer. The bridging oligonucleotide or inverted primer is extended forming a concatemeric amplicon that can then be used as a template to provide exponential amplification of the target nucleic acid.
    Type: Application
    Filed: August 16, 2018
    Publication date: April 18, 2019
    Applicant: Aegea Biotechnologies, Inc.
    Inventors: Lyle J. Arnold, Norman C. Nelson
  • Patent number: 10081825
    Abstract: The present invention provides methods of amplifying a target nucleic acid utilizing a circularized template. Circularization may be achieved utilizing a bridging oligonucleotide or an inverter primer. The bridging oligonucleotide or inverted primer is extended forming a concatemeric amplicon that can then be used as a template to provide exponential amplification of the target nucleic acid.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: September 25, 2018
    Assignee: AEGEA BIOTECHNOLOGIES, INC.
    Inventors: Lyle J. Arnold, Norman C. Nelson
  • Patent number: 10072290
    Abstract: The present invention provides methods of amplifying a fragmented target nucleic acid containing short target nucleic acid fragments utilizing an assembler sequence to convert these short fragments into longer sequences enabling their identification and interrogation. This is particularly important when attempting to identify small genetic variations, such as SNVs, present in highly fragmented nucleic acid samples. Amplification is accomplished by hybridizing the short target nucleic acid sequences to the assembler sequence, where these short sequences serve as primers for extension. Since the fragmented target nucleic acids that contain SNVs are utilized as primers on the assembler sequence they are preserved during amplification and can be detected.
    Type: Grant
    Filed: March 15, 2014
    Date of Patent: September 11, 2018
    Assignee: AEGEA BIOTECHNOLOGIES, INC.
    Inventors: Lyle J. Arnold, Norman C. Nelson
  • Patent number: 10066262
    Abstract: The present invention provides methods of amplifying a target nucleic acid utilizing duplex primer. The first strand of the primer comprises a random nucleotide sequence of about 6 to about 9 nucleotides in length that is able to hybridize to the target nucleic acid and a tag sequence. The second strand of the primer comprises a sequence complementary to the tag sequence allowing the primer to form a duplex and the ability to bind the tag sequence of the product nucleic acid for further amplification. The resulting nucleic acid produced contains tag sequences on both the 3?- and 5?-termini.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: September 4, 2018
    Assignee: AEGEA BIOTECHNOLOGIES, INC.
    Inventor: Lyle J. Arnold